litlas
Log inCreate account

Michael Emerman

Active 1984–2025

92
Papers
24,601
Citations
73
h-index
85
i10-index

Citations

Citations per year for Michael Emerman1982: 1 citations1984: 3 citations1985: 8 citations1986: 13 citations1987: 21 citations1988: 51 citations1989: 55 citations1990: 95 citations1991: 73 citations1992: 82 citations1993: 57 citations1994: 87 citations1995: 117 citations1996: 121 citations1997: 158 citations1998: 203 citations1999: 214 citations2000: 190 citations2001: 166 citations2002: 155 citations2003: 146 citations2004: 172 citations2005: 173 citations2006: 193 citations2007: 196 citations2008: 207 citations2009: 191 citations2010: 201 citations2011: 188 citations2012: 214 citations2013: 175 citations2014: 124 citations2015: 101 citations2016: 120 citations2017: 82 citations2018: 83 citations2019: 302 citations2020: 1,079 citations2021: 1,149 citations2022: 614 citations2023: 305 citations2024: 402 citations2025: 136 citations2026: 4 citations1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,282 citing papers, 35.8% of this breakdownUnited Kingdom: 664 citing papers, 7.3% of this breakdownChina: 641 citing papers, 7% of this breakdownFrance: 494 citing papers, 5.4% of this breakdownGermany: 437 citing papers, 4.8% of this breakdownIndia: 352 citing papers, 3.8% of this breakdownCanada: 313 citing papers, 3.4% of this breakdownItaly: 295 citing papers, 3.2% of this breakdownJapan: 195 citing papers, 2.1% of this breakdownSpain: 176 citing papers, 1.9% of this breakdownSwitzerland: 163 citing papers, 1.8% of this breakdownAustralia: 148 citing papers, 1.6% of this breakdown
0%35.8%Other 21.9%

Institutions

Fields

  • Immunology and Microbiology34.5%
  • Medicine30.2%
  • Biochemistry, Genetics and Molecular Biology24.7%
  • Computer Science4.6%
  • Agricultural and Biological Sciences2.6%
  • Neuroscience1%
  • Other2.4%

Topics

  • HIV Research and Treatment11.5%
  • SARS-CoV-2 and COVID-19 Research7.2%
  • HIV/AIDS drug development and treatment5%
  • COVID-19 Clinical Research Studies4.3%
  • interferon and immune responses3.7%
  • Virus-based gene therapy research3.3%
  • Other65%

Coauthors

All papers

Open in search
  1. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

    Authors: David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M. White, Matthew J. O’Meara, Veronica V. Rezelj, Jeffrey Guo, Danielle L. Swaney, Tia A. Tummino, Ruth Hüttenhain, Robyn M. Kaake, Alicia Richards, Beril Tutuncuoglu, Helene Foussard, Jyoti Batra, Kelsey M. Haas, Maya Modak, Minkyu Kim, Paige Haas, Benjamin J. Polacco, Hannes Braberg, Jacqueline M. Fabius, Manon Eckhardt, Margaret Soucheray, Melanie J. Bennett, Merve Çakır, Michael McGregor, Qiongyu Li, Bjoern Meyer, Ferdinand Roesch, Thomas Vallet, Alice Mac Kain, Lisa Miorin, Elena Moreno, Zun Zar Chi Naing, Yuan Zhou, Shiming Peng, Ying Shi, Ziyang Zhang, Wenqi Shen, Ilsa T. Kirby, James E. Melnyk, John S. Chorba, Kevin Lou, Shizhong Dai, Inigo Barrio‐Hernandez, Danish Memon, Claudia Hernández-Armenta, Jiankun Lyu, Christopher J.P. Mathy, Tina Perica, Kala Bharath Pilla, Sai J. Ganesan, Daniel J. Saltzberg, Ramachandran Rakesh, Liu Xi, Sara B. Rosenthal, Lorenzo Calviello, Srivats Venkataramanan, José Liboy-Lugo, Yizhu Lin, Xi‐Ping Huang, Yongfeng Liu, Stephanie A. Wankowicz, Markus‐Frederik Bohn, Maliheh Safari, Fatima S. Ugur, Cassandra Koh, Nastaran Sadat Savar, Quang Tran, Djoshkun Shengjuler, Sabrina Johanna Fletcher, Michael C. O’Neal, Yiming Cai, Jason C. Chang, David Broadhurst, Saker Klippsten, Phillip P. Sharp, Nicole A. Wenzell, Duygu Kuzuoğlu‐Öztürk, Hao‐Yuan Wang, Raphael Trenker, Janet M. Young, Devin A. Cavero, Joseph Hiatt, Theodore L. Roth, Ujjwal Rathore, Advait Subramanian, Julia Noack, Mathieu Hubert, Robert M. Stroud, Alan D. Frankel, Oren S. Rosenberg, Kliment A. Verba, David A. Agard, Mélanie Ott, Michael Emerman, Natalia Jura and 25 more - Nature 2020 cited by 4,888

  2. Evolutionary conflicts between viruses and restriction factors shape immunity

    Authors: Nisha K. Duggal, Michael Emerman - Nature reviews. Immunology 2012 cited by 375

  3. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV

    Authors: Molly OhAinle, Louisa Helms, Jolien Vermeíre, Ferdinand Roesch, Daryl Humes, Ryan Basom, Jeffrey J. Delrow, Julie Overbaugh, Michael Emerman - eLife 2018 cited by 164

  4. Evolutionary Landscapes of Host-Virus Arms Races

    Authors: Jeannette L. Tenthorey, Michael Emerman, Harmit S. Malik - Annual Review of Immunology 2022 cited by 95

  5. The structural basis for HIV-1 Vif antagonism of human APOBEC3G

    Authors: Yen-Li Li, Caroline Langley, Caleigh M. Azumaya, Ignacia Echeverria, Nicholas M. Chesarino, Michael Emerman, Yifan Cheng, John D. Gross - Nature 2023 cited by 68

  6. Visualization of the intracellular behavior of HIV in living cells

    Authors: David McDonald, Marie A. Vodicka, Ginger Lucero, Tatyana Svitkina, Gary G. Borisy, Michael Emerman, Thomas J. Hope - The Journal of Cell Biology 2002 cited by 798

  7. Positive Selection and Increased Antiviral Activity Associated with the PARP-Containing Isoform of Human Zinc-Finger Antiviral Protein

    Authors: Julie A. Kerns, Michael Emerman, Harmit S. Malik - PLoS Genetics 2008 cited by 214

  8. Positive selection of primate TRIM5 α identifies a critical species-specific retroviral restriction domain

    Authors: Sara L. Sawyer, Lily I. Wu, Michael Emerman, Harmit S. Malik - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 715

  9. Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G

    Authors: Sara L. Sawyer, Michael Emerman, Harmit S. Malik - PLoS Biology 2004 cited by 492

  10. Evolution-Guided Identification of Antiviral Specificity Determinants in the Broadly Acting Interferon-Induced Innate Immunity Factor MxA

    Authors: Patrick S. Mitchell, Corinna Patzina, Michael Emerman, Otto Haller, Harmit S. Malik, Georg Kochs - Cell Host & Microbe 2012 cited by 157

  11. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

    Authors: Paul F. Lewis, Michael Emerman - Journal of Virology 1994 cited by 794

  12. HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment

    Authors: Michael H. Malim, Michael Emerman - Cell Host & Microbe 2008 cited by 549

  13. Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells

    Authors: Masahiro Yamashita, Michael Emerman - Journal of Virology 2004 cited by 322

  14. HIV-1 Sequence Variation

    Authors: Michael H. Malim, Michael Emerman - Cell 2001 cited by 207

  15. Paleovirology—ghosts and gifts of viruses past

    Authors: Maulik Patel, Michael Emerman, Harmit S. Malik - Current Opinion in Virology 2011 cited by 137

  16. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner

    Authors: Molly OhAinle, Kyusik Kim, Sevnur Kömürlü Keceli, Abby Felton, Ed Campbell, Jeremy Luban, Michael Emerman - PLoS Pathogens 2020 cited by 56

  17. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races

    Authors: Jeannette L. Tenthorey, Candice Young, Afeez Sodeinde, Michael Emerman, Harmit S. Malik - eLife 2020 cited by 47

  18. A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection

    Authors: Jessie Kulsuptrakul, Elizabeth A Turcotte, Michael Emerman, Patrick S. Mitchell - eLife 2023 cited by 28

  19. A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency

    Authors: Emily Hsieh, Derek H. Janssens, Patrick J. Paddison, Edward P. Browne, Steve Henikoff, Molly OhAinle, Michael Emerman - PLoS Pathogens 2023 cited by 28

  20. Human immunodeficiency virus infection of cells arrested in the cell cycle.

    Authors: Paul F. Lewis, Michael Hensel, Michael Emerman - The EMBO Journal 1992 cited by 524

  21. Gene Loss and Adaptation to Hominids Underlie the Ancient Origin of HIV-1

    Authors: Lucie Etienne, Beatrice H. Hahn, Paul M. Sharp, Frederick A. Matsen, Michael Emerman - Cell Host & Microbe 2013 cited by 107

  22. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo

    Authors: Wei Chun Goh, M E Rogel, C. Matthew Kinsey, Scott F. Michael, Patricia N. Fultz, Martin A. Nowak, Beatrice H. Hahn, Michael Emerman - Nature Medicine 1998 cited by 511

  23. Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins

    Authors: Rebecca S. LaRue, Valgerður Andrésdóttir, Yannick Blanchard, Silvestro G. Conticello, David Derse, Michael Emerman, Warner C. Greene, S. Jönsson, Nathaniel R. Landau, Martin Löchelt, Harmit S. Malik, Michael H. Malim, Carsten Münk, Stephen J. O’Brien, Vinay K. Pathak, Klaus Strebel, Simon Wain–Hobson, Xiao-Fang Yu, Naoya Yuhki, Reuben S. Harris - Journal of Virology 2008 cited by 228

  24. Retroviral infection of non-dividing cells: Old and new perspectives

    Authors: Masahiro Yamashita, Michael Emerman - Virology 2005 cited by 193